Tag | Content |
---|
EnhancerAtlas ID | HS148-05194 |
Organism | Homo sapiens |
Tissue/cell | NHLF |
Coordinate | chr13:80065080-80067100 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
NEUROD2 | MA0668.1 | chr13:80065338-80065348 | GCCATATGGT | + | 6.02 | ZNF263 | MA0528.1 | chr13:80067019-80067040 | TTCTTTTCTCCCTCCTTCTTC | - | 6.39 | ZNF263 | MA0528.1 | chr13:80067016-80067037 | TTTTTCTTTTCTCCCTCCTTC | - | 7.11 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_19094 | chr13:80065030-80067465 | CD4p_CD25-_Il17-_PMAstim_Th | SE_25521 | chr13:80062973-80069256 | DND41 | SE_35981 | chr13:80063499-80068100 | HMEC | SE_64319 | chr13:80062927-80071865 | NHEK |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH13I079489 | chr13 | 80063289 | 80068117 |
|
Enhancer Sequence | AATCTTCATT CTGTTAGTGT GATTGCCTCA TTGAGGTCAT TCTTGACTAC CTTATTTTAA 60 ATCACTATAT CCCATTCACA GTACTCCTTA TCGCTGTTTC CTGTTTGTTT TTATCCAGAG 120 TACTTATCAT CTTCTGGTAT TCCAAATATT TTGCTTATTT ATTTCCTACC TCCCTTCTTT 180 CTCCCTGAAT TTAAGCCTCA TGGTGGTAGA GAGATTTTTG TCTGTTTTGC TCACTACTGT 240 ATATATCTTT CCATACCTGC CATATGGTAG ACTTTCAGTA TTTGATAAAG ATGAATGAAT 300 GGTGCTAGTT CAAGGCCAAT TTTATAGACA TAAAACCTTG CCTATGTTAT TTTATTCCTT 360 TTTATATTTA TTCTGTTTCT GCTACTGAGA CCTGGGCTCT TTAAGGTGGG GGTGATGGTG 420 GTGGTTGTTT CTTTGCATTC TCTTCCAGCT TGAAATATAT TGCTTAGTCT TCCTCTGTCT 480 CTCTCTCTGA ATGGTGTCCT TTAGAGTTGT TCAATAAGTA GCCCATGAAG CCATATGCAG 540 TGGCCCTGCT TATCACCTTC ATAAACTGCG GAGTTGTGAA TACTGGTTTG ATTTTCCTTA 600 TCTTTTTTAT ATTGATTACT TGGCAACTAT TTTCTTCTTA CTATTTTCTT AATATCTGAC 660 CTTCATTCTA AAACATTGCT CAATTGTATG TGTATTCGCA ATATGTTATT TTAGGATTTT 720 GTATGTATTC TATATATGTA GGCCTGACTT GAGTTTAATT AACTGTGGAA TGGTATGGAA 780 TCTTCTACTG ACGTTTAGTC AATGTAAATT TACTGACAAG ATCACTGTAA TTAAGGCTAT 840 GCAATTGTAA ATCATCGTAT GTCTCTGTTT TCGGGCCATG TTGTTATGGT TTCTTTCAGA 900 TGTTTGATCA CTTAGCTGGA ATTAGGGTGT GGGTAAAATT CTTGTTAAAG ACGTGCCAAA 960 TGCAAGTTGG GAAATGCTGC AGTAGTCTAA GATTTACTGT CAGATTATTT CAGGGTTTTG 1020 ACTTGCTTGC TTTTAAGATT TGTTTGAACA TGTACAGTTT AATATTTTAA AAGTTCAGGA 1080 ATGTGCTGTG GTTTAGTTCA TCTATGATGT TTCTCCAGAA TTACTCATAA CATTATGTAA 1140 AGAAATTGTG CTATTTGGAC AGAGGTTTTG AGAATAAGGG AGTGAACTGG ATTTCATTTT 1200 GTAAAAGAAT CTTCTAATGT GATGGTATTA ACCCCTTTAC TAATTTTGGG GGTCTTAGGA 1260 CATATAGCCT TTTGGATATT GGACTGAGGA AATCCAGTAG TGACACCTTT TTTTTTTTTT 1320 TTTTCCTTTC TTTATAAGTG TTCAAAGTGA CAGCTTTTGT AGAACATTTG TTCTCCTCAC 1380 CTCGGGAGAG CTTTCATCTA TATCAGATGA CTTTTTGTGT GATTTCTGTC AAAAGGGAAG 1440 AGTCTTGAAA TAACACTTGA GAGTTTTGTT TTTTTTGAGG CAGAGTCTCG CTGTGTCACC 1500 CAGGCTGGAG TGCAGTCTGG TGGATCACAG CACTGCAGCC CTAACCTTCT GAGTTCAAGC 1560 GGTCTTCCCC CTCAGCCTCC CAAGTAGTTG AGACTACAGG CATGCATCAC CACGCTTGGC 1620 TGAATTTTTT CTTTTTTAGA GATAGAGTCT TACTATGTTG CCCAGTCTGT TCTCAAATCA 1680 TTTTTCTGCC TTGGCTTCCC AAAGTGCTGG GATTACTGAC ATGAGCCACT GTTCCTGGCC 1740 ACACTTAAGG CCCTTTTAAG TATTTGTTTT TAACCTTTAG AGAACAACAG GAGCACCTGC 1800 ATACCTCATC CCTGCCTACG TTGTTACTGC ATTGCATACT TTGGCCATGT TTTAAACTAT 1860 AATGCTTTTG TTTCTCTATC ACCACCCCAA ATCATGCTAT CTCTTGCTTT GTAGCTTTTA 1920 AATATATCTT TCCCATTTTT TCTTTTCTCC CTCCTTCTTC CAGGACTAAT TTCAATTGTG 1980 TATTCAGATC TATATTTAGA TGTTATTTTC TTCAAAAAAC 2020
|